A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients
Clinical trial NCT00002218 · COMPLETED
Trial details
- NCT number
- NCT00002218
- Sponsor
- Parke-Davis
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.